17-AAG is a less toxic and more stable analog of geldanamycin. It is an HSP90 inhibitor that displays a 100-fold higher affinity for HSP90 derived from tumor cells compared to HSP90 from normal cells. 17-AAG inhibits Akt activation and expression in tumo
Molecular Weight:
585.7
Source:
Semisynthetic derivative from geldanamycin.
Purity:
98% (TLC)
CAS Number:
[75747-14-7]
Formula:
C31H43N3O8
Target:
HSP90
* VAT and and shipping costs not included. Errors and price changes excepted